GCM
JNJ icon

Genus Capital Management’s Johnson & Johnson JNJ Stock Holding History

Genus Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,550
Closed -$224K – 280
2024
Q4 		$224K Hold
1,550
– – 0.03% 177
2024
Q3 		$251K Hold
1,550
– – 0.03% 176
2024
Q2 		$227K Buy
+1,550
New +$231K 0.03% 176
2024
Q1 		– Sell
-1,890
Closed -$296K – 299
2023
Q4 		$296K Buy
+1,890
New +$290K 0.04% 166

Other funds holding JNJ

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Genus Capital Management's JNJ Position: Q2 2026 in Review

Genus Capital Management reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $1.65M and leaving 48,853 shares worth $12.4M. The position accounts for 1.22% of the portfolio, ranked #23.

Genus Capital Management first reported a position in JNJ in Q2 2023 and has held it in 9 quarters since. The position peaked at $13.7M in Q1 2026. 2,615 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Genus Capital Management held 48,853 shares of Johnson & Johnson worth $12.4M as of Q2 2026.
  • Genus Capital Management sold 7,082 Johnson & Johnson shares in Q2 2026, an estimated $1.65M.
  • Johnson & Johnson made up 1.22% of Genus Capital Management's portfolio in Q2 2026, its #23 holding.
  • Genus Capital Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 9 quarters since.
  • Genus Capital Management's Johnson & Johnson position peaked at $13.7M in Q1 2026.
  • 2,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.